Therapeutic Misconception
"Therapeutic Misconception" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.
| Descriptor ID |
D055990
|
| MeSH Number(s) |
I01.880.604.473.650.960 K01.752.566.479.173.850 N05.350.670.875
|
| Concept/Terms |
Therapeutic Misconception- Therapeutic Misconception
- Misconception, Therapeutic
- Misconceptions, Therapeutic
- Therapeutic Misconceptions
|
Below are MeSH descriptors whose meaning is more general than "Therapeutic Misconception".
Below are MeSH descriptors whose meaning is more specific than "Therapeutic Misconception".
This graph shows the total number of publications written about "Therapeutic Misconception" by people in this website by year, and whether "Therapeutic Misconception" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Therapeutic Misconception" by people in Profiles.
-
"Medical Benefit" and Therapeutic Misconception: The Ethical Conundrum of Phase 1 Pediatric Oncology Research. J Pediatr. 2021 11; 238:11-13.
-
Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials. J Empir Res Hum Res Ethics. 2017 10; 12(4):280-288.
-
Dispositional optimism and therapeutic expectations in early-phase oncology trials. Cancer. 2016 Apr 15; 122(8):1238-46.
-
Incidental findings of therapeutic misconception in biobank-based research. Genet Med. 2012 Jun; 14(6):611-5.
-
The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials. Cancer. 2010 Aug 01; 116(15):3702-11.